Antibodies in Myasthenia Gravis and Related Disorders
- 1 September 2003
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 998 (1), 324-335
- https://doi.org/10.1196/annals.1254.036
Abstract
Acetylcholine receptor (AChR) antibodies are present in around 85% of patients with myasthenia gravis (MG) as measured by the conventional radioimmunoprecipitation assay. Antibodies that block the fetal form of the AChR are occasionally present in mothers who develop MG after pregnancy, especially in those whose babies are born with arthrogryposis multiplex congenita. The antibodies cross the placenta and block neuromuscular transmission, leading to joint deformities and often stillbirth. In these mothers, antibodies made in the thymus are mainly specific for fetal AChR and show restricted germline origins, suggesting a highly mutated clonal response; subsequent spread to involve adult AChR could explain development of maternal MG in those cases who first present after pregnancy. In the 15% of “seronegative” MG patients without AChR antibodies (SNMG), there are serum factors that increase AChR phosphorylation and reduce AChR function, probably acting via a different membrane receptor. These factors are not IgG and could be IgM or even non-Ig serum proteins. In a proportion of SNMG patients, however, IgG antibodies to the muscle-specific kinase, MuSK, are present. These antibodies are not found in AChR antibody-positive MG and are predominantly IgG4. MuSK antibody positivity appears to be associated with more severe bulbar disease that can be difficult to treat effectively.Keywords
This publication has 33 references indexed in Scilit:
- Expression of Soluble Ligand- and Antibody-binding Extracellular Domain of Human Muscle Acetylcholine Receptor α Subunit in Yeast Pichia pastorisPublished by Elsevier BV ,2002
- The conformation of the main immunogenic region on the α‐subunit of muscle acetylcholine receptor is affected by neighboring receptor subunitsFEBS Letters, 2000
- Physicochemical and immunological studies of the N‐terminal domain of the Torpedo acetylcholine receptor α‐subunit expressed in Escherichia coliJBIC Journal of Biological Inorganic Chemistry, 1999
- Acquired slow–channel syndrome: A form of myasthenia gravis with prolonged open time of the acetylcholine receptor channelAnnals of Neurology, 1998
- Seronegative Myasthenia Plasmas and Non‐IgG Fractions Transiently Inhibit nAChR FunctionaAnnals of the New York Academy of Sciences, 1998
- Myasthenia Gravis and Elderly PeopleAge and Ageing, 1996
- A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitroMuscle & Nerve, 1990
- The Membrane Attack Complex of Complement at the Endplate in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1987
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986
- Diaphragmatic myasthenia in mother and childPostgraduate Medical Journal, 1985